Pemphigus vulgaris following radiotherapy in head and neck cancer: Clinicopathological perspective of a rare cutaneous manifestation after radiotherapy treatment

Pemphigus vulgaris triggered by the radiotherapy is rare and very few cases have been reported in the literature. Lesions within the radiotherapy field can be difficult to differentiate from post radiation dermatitis. Though exact pathogenesis is not understood, radiotherapy induced immunomodulation leading to bullous skin lesions, is thought to be critical. Here we present the clinicopathological perspective of pemphigus vulgaris involving the skin within and outside the radiotherapy portal, presented 2 weeks after the completion of radiotherapy. The condition requires multidisciplinary management and close coordination between oncologist, dermatologist, and dermatopathologist. Diagnosis is established based on the clinical presentation, histopathology, and direct immunofluorescence examination. Early institution of immunosuppressive therapy can improve the skin lesions and reduce the morbidity significantly.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Research and Therapeutics
Published
2025-04-01
DOI
https://doi.org/10.4103/jcrt.jcrt_1941_24
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pemphigus vulgaris following radiotherapy in head and neck cancer: Clinicopathological perspective of a rare cutaneous manifestation after radiotherapy treatment

Rajesh Pasricha, Saikat Das, Vipin Kharade, Arnav Tiwari et al.
Journal of Cancer Research and Therapeutics
Autoimmune Bullous Skin Diseases
article

Pemphigus vulgaris following radiotherapy in head and neck cancer: Clinicopathological perspective of a rare cutaneous manifestation after radiotherapy treatment

Rajesh Pasricha, Saikat Das, Vipin Kharade, Arnav Tiwari, Vaishali Walke, Manish Gupta, Dinesh Asati
article en

Abstract

Pemphigus vulgaris triggered by the radiotherapy is rare and very few cases have been reported in the literature. Lesions within the radiotherapy field can be difficult to differentiate from post radiation dermatitis. Though exact pathogenesis is not understood, radiotherapy induced immunomodulation leading to bullous skin lesions, is thought to be critical. Here we present the clinicopathological perspective of pemphigus vulgaris involving the skin within and outside the radiotherapy portal, presented 2 weeks after the completion of radiotherapy. The condition requires multidisciplinary management and close coordination between oncologist, dermatologist, and dermatopathologist. Diagnosis is established based on the clinical presentation, histopathology, and direct immunofluorescence examination. Early institution of immunosuppressive therapy can improve the skin lesions and reduce the morbidity significantly.

Journal of Cancer Research and TherapeuticsVol. 21(3)
All India Institute of Medical Sciences Bhopal (IN)
Good health and well-being
Openalex Percentile: Top 76%
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pemphigus vulgaris following radiotherapy in head and neck cancer: Clinicopathological perspective of a rare cutaneous manifestation after radiotherapy treatment — Rajesh Pasricha, Saikat Das, et al. · Journal of Cancer Research and Therapeutics (2025) | TGRS Research Map | TGRS